2021 - 12 - 13
Successful trial phase for treatment of COVID-19 induced hypoxemia Phase IIb clinical trial executed with Medspray nozzle technology for treatment of COVID-19 induced hypoxemia. Our daughter company Resyca has supplied […]
2021 - 10 - 05
Wilbur de Kruijf was one of the first employees at Medspray. He worked at Medspray from 2002 to 2020, establishing pharmaceutical applications of the Medspray nozzle technology. Since 2021 he […]
2021 - 06 - 22
By providing expertise and equipment to a group of researchers of the Royal Netherlands Aerospace Centre (NLR) and the Dutch National Institute for Public Health and the Environment (RIVM), Medspray […]
2021 - 06 - 02
Medspray Pharma BV has secured funding from the Bill & Melinda Gates Foundation to develop a new way of delivering medication to babies. We aim to develop a new, non-invasive […]
2021 - 02 - 02
Medspray has joined forces with contract development and manufacturing organization Recipharm in the joint venture Resyca BV. Together, they will develop and exploit a unique soft mist spray nozzle technology […]
2021 - 01 - 19
The first sustainable spray deodorant revolutionizes the industry! Imagine a spray deodorant that does not need Volatile Organic Compounds (VOC’s). That is what we envisioned and are now realizing in […]
Showing 3 - 4 of 23 results
Design: Brand Specials